(Q46170423)

20 December 2017

title

Recombinant growth hormone treatment of amyotrophic lateral sclerosis (English)

1 reference

20 December 2017

amyotrophic lateral sclerosis

main subject

0 references

author name string

Smith RA

1

1 reference

20 December 2017

Melmed S

2

1 reference

20 December 2017

Sherman B

3

1 reference

20 December 2017

Frane J

4

1 reference

20 December 2017

Munsat TL

5

1 reference

20 December 2017

Festoff BW

6

1 reference

20 December 2017

publication date

1 June 1993

1 reference

20 December 2017

published in

Muscle and Nerve

1 reference

20 December 2017

volume

16

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

624-633

1 reference

20 December 2017

Nonketotic hyperglycinemia: studies in an atypical variant.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

ALS in Rochester, Minnesota, 1925-1977.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

Pituitary tumors secreting growth hormone and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

The natural history of motoneuron loss in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

Hyposomatomedinemia in men with post-poliomyelitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880160608

21 January 2018

Identifiers

DOI

10.1002/MUS.880160608

1 reference

20 December 2017

PubMed ID

8502260

1 reference

20 December 2017